COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study
Barraclough, Allison, Alzahrani, Musa, Ettrup, Marianne Schmidt, Bishton, Mark, van Vliet, Chris, Farinha, Pedro, Gould, Clare, Birch, Simone, Sehn, Laurie H., Sovani, Vishakha, Ward, Mitchell Steven, Augustson, Bradley, Biccler, Jorne, Connors, Joseph M., Scott, David W., Gandhi, Maher K., Savage, Kerry J., El-Galaly, Tarec, Villa, Diego, Cheah, Chan Yoon
Published in Blood advances (09.07.2019)
Published in Blood advances (09.07.2019)
Get full text
Journal Article
Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study
Barraclough, Allison, Alzahrani, Musa, Schmidt Ettrup, Marianne, Bishton, Mark, Van Vliet, Chris, Sehn, Laurie H., Sovani, Vishakha, Ward, Mitchell Steven, Augustson, Bradley, Farinha, Pedro, Biccler, Jorne Lionel, Connors, Joseph M, Scott, David W., Savage, Kerry J, El-Galaly, Tarec Christoffer, Villa, Diego, Cheah, Chan Yoon
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article